High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers

Model NO.
90098-04-7
Packing 6-20kg
Plastic Bag Inside and Carton Box Outside
Package
Aluminum Foil Bag; Fib Drum
CAS
90098-04-7
Product Name
Rebamipide
Transport Package
25kg/Drum
Specification
25kg/Drum
Trademark
Wuhan Kaimubuke Pharmaceutical Technology Co., Ltd
Origin
China
HS Code
2934999090
Production Capacity
1ton/Month
Reference Price
$ 14.58 - 16.20
Contact Us

Product Description

Product Description

Rebamipide CAS 90098-04-7 for Stomach Ulcers

Product Name: Rebamipide
Synonyms: (+-)-1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoica;(+-)-2-(4-chlorobenzoylamino)-3-(2(1h)-quinolinon-4-yl)propionicacid;Mucosta;Proamipide;2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo- (+-)-4-quinolinepropanoic acid;2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl);2-(4-CHLOROBENZAMIDO)-3-(2-OXO-1,2-DIHYDROQUINOLIN-4-YL)PROPANOIC ACID;OPC-12759, Mucosta, α-[(4-Chlorobenzoyl)-amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic Acid
CAS: 90098-04-7
MF: C19H15ClN2O4
MW: 370.79
EINECS: 621-260-7
 

BATCH NO.: HF171202 QUANTITY:75.1kg
MFG. DATE : Dec., 2, 2023 SPECIFICATION: As required
REP. DATE : Dec.4, 2023 EXP. DATE : Dec., 2023
ITEMS

STANDARDS

RESULTS

Appearance

White or off-white crystalline powder Off-white crystalline powder
Identification By IR Complies
RT under chirality should complies Complies
Chloride: it gives a reaction of chloride Complies
Water          3.0%~4.5% 3.4%

Melting Point

198.0~202.0ºC 199.8~200.5ºC
Residue on Ignition ≤0.2% 0.08%
Heavy Metals ≤10ppm Complies
Related Substances Individual Impurities:≤0.5% 0.15%
Total Impurities:≤1.0% 0.22%
Residual Solvent Dichlorometh ≤0.06% 0.0066%
Aceto ≤0.5% 0.015%
 ≤0.5% 0.0013%
E.E ≥99.0% 99.6%

Assay (on dry basis)

98.0%~102.0% 101.2%
Conclusion:It complies to prescribed enterprise standard.

What is Rebamipide?
Rebamipide, also known as rebapide, is a new type of anti-ulcer drug. In 1990, it was first marketed in Japan as a drug for gastric ulcer and acute and chronic gastritis. Rebamipide is a gastric mucosal protectant, which can increase the blood flow of gastric mucosa, the synthesis of prostagland E2 and gastric mucus secretion.
It can promote the expression of epidermal   its receptor Chemicalbook, prevent ulcer and promote ulcer healing.
Studies have shown that it is effective for various experimental gastric ulcers, can promote the production of prostagland in gastric mucosa, protect gastric mucosa from the harm of various ulcer-causing factors, suitable for the treatment of gastric ulcers, acute gastritis, acute aggravation of chronic gastritis, gastric mucosa lesions, has a high clinical value.

Detailed Photos

 

High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers
High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers
High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers
High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers
High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers

 

Hot sale product

NMN CAS: 1094-61-7 
Nr CAS: 1341-23-7 
Acetaminophen CAS :103-90-2 
Boric acid CAS : 11113-50-1 
Tetracain hcl CAS :136-47-0 
Valerophenoone CAS :1009-14-9 
4'-Methylpropiophenone CAS 5337-93-9

Ethephon CAS:16672-87-0 
New BMK CAS:20320-59-6
(2-Bromoethyl)benzene CAS:103-63-9 
Clotrimazole CAS:23593-75-1 
Tretinoin CAS:302-79-4 
4'-Methylpropiophenone CAS 5337-93-9 
Benzene CAS 103-63-9

Packaging & Shipping

 

By Express By Air By Sea
Suitable for under 50kg Suitable for more than 50kg Suitable for more than 500kg
Fast: 3-7 days Fast: 3-7 days slow: 3-7 days
High cost Medium cost Low cost
Door to door service Port to port service Port to port service
 
High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers
 
High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers
 
 

Company Profile

High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers

 

Our Advantages

 

High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers

 

FAQ

 

 
High Quality Rebamipide CAS 90098-04-7 for Stomach Ulcers
 
 

 

 

 

Pharmaceutical Intermediate

PNEUTEC.IT, 2023